BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 15246205)

  • 1. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study.
    Córdoba J; López-Hellín J; Planas M; Sabín P; Sanpedro F; Castro F; Esteban R; Guardia J
    J Hepatol; 2004 Jul; 41(1):38-43. PubMed ID: 15246205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of hepatic encephalopathy using a modified high-calorie high-protein diet.
    Gheorghe L; Iacob R; Vădan R; Iacob S; Gheorghe C
    Rom J Gastroenterol; 2005 Sep; 14(3):231-8. PubMed ID: 16200232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-protein diets for hepatic encephalopathy debunked: let them eat steak.
    Cabral CM; Burns DL
    Nutr Clin Pract; 2011 Apr; 26(2):155-9. PubMed ID: 21447768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal protein diet and L-ornithine-L-aspartate for hepatic encephalopathy.
    Ndraha S; Simadibrata M
    Acta Med Indones; 2010 Jul; 42(3):158-61. PubMed ID: 20724770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein restriction in hepatic encephalopathy: necessary evil or illogical dogma?
    Mullen KD; Dasarathy S
    J Hepatol; 2004 Jul; 41(1):147-8. PubMed ID: 15246221
    [No Abstract]   [Full Text] [Related]  

  • 6. Dietary protein supplementation from vegetable sources in the management of chronic portal systemic encephalopathy.
    Keshavarzian A; Meek J; Sutton C; Emery VM; Hughes EA; Hodgson HJ
    Am J Gastroenterol; 1984 Dec; 79(12):945-9. PubMed ID: 6391154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The dietary protein contribution and hepatic encephalopathy in cirrhosis].
    Zavaglia C; Brivio M; Losacco E; Onida L
    Recenti Prog Med; 1992 Apr; 83(4):218-23. PubMed ID: 1626117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutrition in the management of hepatic encephalopathy.
    Srivastava N; Singh N; Joshi YK
    Trop Gastroenterol; 2003; 24(2):59-62. PubMed ID: 14603821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal transit in cirrhotic patients: effect of hepatic encephalopathy and its treatment.
    Van Thiel DH; Fagiuoli S; Wright HI; Chien MC; Gavaler JS
    Hepatology; 1994 Jan; 19(1):67-71. PubMed ID: 8276369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of an orally administered protein mixture enriched in branched chain amino acids on the chronic hepatic encephalopathy (CHE) of patients with liver cirrhosis.
    Schäfer K; Winther MB; Ukida M; Leweling H; Reiter HJ; Bode JC
    Z Gastroenterol; 1981 Jul; 19(7):356-62. PubMed ID: 7293293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of hepatic encephalopathy with oral zinc supplementation: a long-term treatment.
    Bresci G; Parisi G; Banti S
    Eur J Med; 1993; 2(7):414-6. PubMed ID: 8258031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of differentiated diet therapy on the clinical results and biochemical indicators in chronic hepatic encephalopathy].
    Szpakowicz T; Boroń P; Flisiak R; Bobrowska E; Kaczmarska A; Nowak HF; Zimnoch L
    Przegl Lek; 1990; 47(7):527-31. PubMed ID: 2284419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy.
    Ahmad I; Khan AA; Alam A; Dilshad A; Butt AK; Shafqat F; Malik K; Sarwar S
    J Coll Physicians Surg Pak; 2008 Nov; 18(11):684-7. PubMed ID: 18983791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
    Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
    Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of nutrition in hepatic encephalopathy.
    Schulz GJ; Campos AC; Coelho JC
    Curr Opin Clin Nutr Metab Care; 2008 May; 11(3):275-80. PubMed ID: 18403924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin for rats with thioacetamide-induced liver failure and encephalopathy.
    Huang HC; Wang SS; Lee FY; Chan CY; Chang FY; Lin HC; Chu CJ; Chen YC; Lee SD
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e236-42. PubMed ID: 17573832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclinical hepatic encephalopathy: role of tryptophan binding to albumin and the competition with indole-3-acetic acid.
    Greco AV; Mingrone G; Favuzzi A; Bertuzzi A; Gandolfi A; DeSmet R; Vanholder R; Gasbarrini G
    J Investig Med; 2000 Jul; 48(4):274-80. PubMed ID: 10916286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dispelling myths in the treatment of hepatic encephalopathy.
    Shawcross D; Jalan R
    Lancet; 2005 Jan 29-Feb 4; 365(9457):431-3. PubMed ID: 15680459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertyraminemia in cirrhotic patients.
    Faraj BA; Bowen PA; Isaacs JW; Rudman D
    N Engl J Med; 1976 Jun; 294(25):1360-4. PubMed ID: 772438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary and nutritional indications in hepatic encephalopathy.
    Merli M; Riggio O
    Metab Brain Dis; 2009 Mar; 24(1):211-21. PubMed ID: 19052853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.